Intellipharmaceutics International Inc Net Income per Employee (IPCIF), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Intellipharmaceutics International Inc   (IPCIF)
 

Intellipharmaceutics International Inc Net Income per Employee

IPCIF's Quarterly Results, Trends, Rankings, Statistics
Intellipharmaceutics International Inc recorded a cumulative net loss of $-5 million during 12 month ending in the third quarter 2023.
The Healthcare sector has seen employees of 118 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 3506, from total ranking in previous quarter at 3510.


What is Income per Employee Ratio?






IPCIF Net Income per Employee (Aug 31 2023)
III. Quarter
(May 31 2023)
II. Quarter
(Feb 28 2023)
I. Quarter
(Nov 30 2022)
IV. Quarter
0
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -103,830 -73,205 -88,936 -99,440 -66,878
IPCIF's Total Ranking # 3506 # 3510 # 0 # #
Seq. Net Income Change - - - - -


IPCIF Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 119
Healthcare Sector # 346
Overall Market # 3506

Net Income per Employee Statistics
High Average Low
$ -57,848 $ -138,086 $ -229,900
(Nov 30 2022)   (Nov 30 2013)







Companies with similar Income per Employee for 12 month ending Aug 31 2023, within Healthcare Sector Income per Employee Income 12 month ending Aug 31 2023Number of Employees Aug 31 2023


Date modified: 2026-09-12T06:20:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.